- Tests are DHA-approved, and the results connect directly with AL HOSN application
Dubai, UAE: Okadoc, the one-stop-shop patient engagement platform, now offers at-home PCR testing. For 150 AED, Dubai residents can order quick and reliable PCR tests from the convenience of their own homes.
The tests are DHA-approved with results connecting directly with the UAE’s AL HOSN application. Powered by Unilabs, results are guaranteed within 12 hours.
“As we expand our offering to include home services, we will continue to deliver the same patient experience that our users know and deserve. With Okadoc, patients can book PCR tests from wherever they are with confidence, knowing they will get the care they need without delays.” says Fodhil Benturquia, Okadoc CEO and Founder.
Okadoc’s platform also allows patients to schedule COVID-19 vaccination from a wide range of hospitals and clinics, including Emirates Hospital, Medcare, Valiant Clinic & Hospital and HealthPlus, allowing patients to book a free vaccination of their choice within seconds near a facility that suits them best.
Okadoc continues to support the UAE’s world-leading COVID-19 vaccination and testing program by offering patients an easy and convenient way to book. Since the launch of Okadoc’s COVID-19 services in February 2021, the doctor booking platform has already helped UAE residents book over 40,000 vaccinations and more than 71,000 COVID-19 tests.
In addition to COVID-19 vaccination and testing appointments, the Okadoc platform allows patients to find doctors across more than 300 facilities and instantly book virtual or in-person appointments across a wide variety specialties.
The Middle East’s best-funded startup fast tracked its telehealth offering in response to the growing need for remote healthcare during the COVID-19 pandemic. In May of 2020, it introduced its telemedicine platform, enabling more than 75,000 virtual consultations with over 1,000 doctors, including the ability to settle fees online. In 2021, Okadoc managed over four million appointments across the UAE, Middle East and Indonesia – a 7x growth in appointments between fiscal year 2020 and 2021.
For more information, please visit www.okadoc.com or download the Okadoc app from Apple App Store or Google Play.
-Ends-
About Okadoc:
Okadoc is a one-stop-shop patient engagement platform based in the UAE that helps providers seamlessly connect with their patients.
For health systems and plans, Okadoc is a technology partner that increases operational efficiency and improves patient engagement and retention. For patients, it’s an all-in-one platform that digitizes the patient experience and provides access to quality care, resulting in better health outcomes.
Okadoc’s white-labeled solution is trusted by the region’s leading healthcare and payor groups As the best-funded healthtech startup in the GCC, Okadoc aims to improve the healthcare experience for all.
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
